Page 11234..»

You are currently browsing the Quantum Medicine category

In Waterloo they’re looking for nature’s deepest and weirdest secrets – National Observer

§ October 19th, 2020 § Filed under Quantum Medicine Comments Off on In Waterloo they’re looking for nature’s deepest and weirdest secrets – National Observer

Tim Hsieh, a theoretical physicist, pauses when asked what he studies for a living.

"It's pretty tricky, to be honest," acknowledges Hsieh, a faculty member at the newly created Clay Riddell Centre for Quantum Matter at the Perimeter Institute for Theoretical Physics in Waterloo, Ont.

"It's kind of a different way of thinking about physics. Quantum matter is a very different philosophy."

But there's no hesitation when he talks about the possibilities that may emerge from the brains and blackboards at the centre.

"This is one of the most open-minded places I've ever been."

The centre is the result of a $10-million donation announced this week from the Riddell Family Foundation set up by Clay Riddell, who was a Calgary businessman and philanthropist.

It's the largest single donation since the institute's founding two decades ago. The money will aid Canadian researchers to probe some of the deepest and strangest properties of the world within the atom and, maybe, make breakthroughs toward a next generation of supercomputers or impossibly efficient power grids.

Quantum mechanics is what happens to physics when it gets really, really small, said centre director Rob Myers.

"When you go to the scale of atoms or even smaller, the rules of how the universe works change."

Predictions go from certainties to probabilities. Seemingly unconnected particles affect each other in ways Isaac Newton never dreamed of and that Albert Einstein once called "spooky action at a distance."

Understanding that spooky action is what scientists like Hsieh and others at the new centre are doing. The results, said Myers, will be profound.

Quantum computers will be able to do calculations that would take traditional computers thousands of years. Ultrasensitive quantum sensors could reshape medicine or environmental monitoring.

Quantum cybersecurity could be virtually unhackable. Quantum-based superconductors could transmit electricity without losing any of it.

The institute has already been an integral part of research that brought the world its first images of a black hole.

But the best stuff probably hasn't even been thought of yet, Myers said. Think of how cellphones science fiction a generation ago have changed society.

"We hope the theoretical work we're doing here builds the foundation for the cellphones of the future. (Our scientists) are thinking about the big questions and swinging for the fences."

Hsieh said his work, day to day, isn't that grandiose. He reads others' research and confers with both theoretical and experimental colleagues.

"Also, a lot of daydreaming," he said, "hopefully constructive. It's a very non-linear process. You just keep following your nose and what you think is fundamentally interesting."

The value of places such as the new centre is in bringing people together who are looking at similar phenomena from different angles and letting them work things out, Hsieh said.

"When you bring together a group of people, you have a lot of inspiration from ways of looking at the same material a lot of flow of ideas."

The institute and its new Riddell Centre are one of very few places in the world where this kind of work goes on, he said.

"People (here) have no boundaries and they're very willing to listen to your work," said Hsieh. "When you couple that to this field of quantum matter, you really get a lot of potential for breakthroughs with high, real-world impacts."

This report by The Canadian Press was first published Oct. 16, 2020.

Excerpt from:

In Waterloo they're looking for nature's deepest and weirdest secrets - National Observer

Read the Rest...

Forum Teratec 2020 Gathered Experts in Simulation, HPC, Big Data and AI – HPCwire

§ October 19th, 2020 § Filed under Quantum Medicine Comments Off on Forum Teratec 2020 Gathered Experts in Simulation, HPC, Big Data and AI – HPCwire

Oct. 19, 2020 Held in digital format on October 13 and 14, 2020, given the circumstances of COVID-19, Forum Teratec gathered over 1200 experts in Simulation, HPC, Big Data and Artificial Intelligence. It brought together industrialists, users, suppliers and political decision-makers around the essential issue of digital. As President of Teratec Daniel Verwaerde said in his introduction: This crisis demonstrates the fundamental importance of digital, and especially HPC and HPDA in our lives and in our economy.

The Forum Teratec 2020 was up to the challenge of previous years editions, welcoming more than 1,200 participants. It brought together major European decision-makers virtually, including Thierry Breton, the European Commissioner, Florence Parly, the French Minister of the Armed Forces and many industrialists. More than sixty companies and innovative projects presented their latest results with the ability for participants to share experiences during business meetings. In addition, six thematic workshops attended by national and international experts provided an opportunity to review the latest technological advances, in the fields of digital-twin in medicine, quantum computing, satellite data and the environment, AI and scientific computing, Cloud computing and HPC or Exascale.

One strategic stake, both political and economical

In all economic fields, these technologies will be essential and companies able to master them will be the leaders of tomorrow. Thierry Breton, European Commissioner for the Internal Market clearly stated: High-Performance Computing represents a major strategic challenge for Europe as much industrial, technological and, of course, scientific. It is also one of the pillars of our digital autonomy.

Digital autonomy for European States will require the implementation of a network of supercomputers on their territory for all users in industry, research and the public sector.

The European Commission has identified HPC as one of key pillars of the digital decade and decided to invest, together with Member States and industry, more than 8 billion in new-generation supercomputers under the EuroHPC Joint Undertaking.

Beyond supercomputers, European sovereignty is also conditioned by Europes ability to produce processors at best global scope, in order to reduce its dependence in this strategic area. It is also in the process of bringing together all the players involved (research organizations, small and large enterprises, public authorities) within digital ecosystems capable of mastering those technologies that will guarantee Europes competitiveness in the global economy.

Key technologies for all economic sectors

For Florence Parly, French Minister of the Armed Forces: Artificial Intelligence, High-Performance Computing, Quantum computing and, more generally, breakthrough innovations linked to data are subjects of prime importance for the Ministry of the Armed Forces. They are therefore at the heart of innovation and investment strategies, with the aim of devoting them 1 billion a year from 2022.

HPC in the COVID-19 era

During the roundtable discussion How can digital technology serve health in the age of COVID-19?, major sponsors of the Forum Teratec discussed the contribution of HPC and HPDA to the health sector, with obvious particular focus on the COVID-19 pandemic. They were thus able to demonstrate the value of these technologies in the management of the pandemic and in research for treatments and vaccines.

Innovation is core for the 6th Trophies for Simulation and AI 2020

The 6th Simulation and AI 2020 Trophies, organized with LUsine Digitale in partnership with Ansys, the CEA, Inria and Smart 4D, rewarded innovative projects or companies that have carried out an outstanding operation in the field of digital simulation, high-performance computing, Big Data or AI, or their application to healthcare. For each category, the winners are:

Closing the Forum Teratec, Daniel Verwaerde concluded: The Forum Teratec 2020 has shown the major importance of HPC and HPDA for the management of the health crisis and for industrial recovery. I would like to thank over than 1,200 participants who made it a remarkable success, and I look forward to seeing them again at the Forum Teratec 2021 next June, 22 and 23.

https://teratec.eu/forum

Source: Teratec

Read more here:

Forum Teratec 2020 Gathered Experts in Simulation, HPC, Big Data and AI - HPCwire

Read the Rest...

DeepMind open-sources the FermiNet, a neural network that simulates electron behaviors – VentureBeat

§ October 19th, 2020 § Filed under Quantum Medicine Comments Off on DeepMind open-sources the FermiNet, a neural network that simulates electron behaviors – VentureBeat

In September, Alphabets DeepMind published a paper in the journal Physical Review Research detailing Fermionic Neural Network (FermiNet), a new neural network architecture thats well-suited to modeling the quantum state of large collections of electrons. The FermiNet, which DeepMind claims is one of the first demonstrations of AI for computing atomic energy, is now available in open source on GitHub and ostensibly remains one of the most accurate methods to date.

In quantum systems, particles like electrons dont have exact locations. Their positions are instead described by a probability cloud. Representing the state of a quantum system is challenging, because probabilities have to be assigned to possible configurations of electron positions. These are encoded in the wavefunction, which assigns a positive or negative number to every configuration of electrons; the wavefunction squared gives the probability of finding the system in that configuration.

The space of possible configurations is enormous represented as a grid with 100 points along each dimension, the number of electron configurations for the silicon atom would be larger than the number of atoms in the universe. Researchers at DeepMind believed that AI could help in this regard. They surmised that, given neural networks have historically fit high-dimensional functions in artificial intelligence problems, they could be used to represent quantum wavefunctions as well.

Above: Simulated electrons sampled from the FermiNet move around a bicyclobutane molecule.

By way of refresher, neural networks contain neurons (mathematical functions) arranged in layers that transmit signals from input data and slowly adjust the synaptic strength i.e., weights of each connection. Thats how they extract features and learn to make predictions.

Because electrons are a type of particle known as fermions, which include the building blocks of most matter (e.g., protons, neutrons, quarks, and neutrinos), their wavefunction has to be antisymmetric. (If you swap the position of two electrons, the wavefunction gets multiplied by -1, meaning that if two electrons are on top of each other, the wavefunction and the probability of that configuration will be zero.) This led the DeepMind researchers to develop a new type of neural network that was antisymmetric with respect to its inputs the FermiNet and that has a separate stream of information for each electron. In practice, the FermiNet averages together information from across streams and passes this information to each stream at the next layer. This way, the streams have the right symmetry properties to create an antisymmetric function.

Above: The FermiNets architecture.

The FermiNet picks a random selection of electron configurations, evaluates the energy locally at each arrangement of electrons, and adds up the contributions from each arrangement. Since the wavefunction squared gives the probability of observing an arrangement of particles in any location, the FermiNet can generate samples from the wavefunction directly. The inputs used to train the neural network are generated by the neural network itself, in effect.

We think the FermiNet is the start of great things to come for the fusion of deep learning and computational quantum chemistry. Most of the systems weve looked at so far are well-studied and well-understood. But just as the first good results with deep learning in other fields led to a burst of follow-up work and rapid progress, we hope that the FermiNet will inspire lots of work on scaling up and many ideas for new, even better network architectures, DeepMind wrote in a blog post. We have just scratched the surface of computational quantum physics, and look forward to applying the FermiNet to tough problems in material science and condensed matter physics as well. Mostly, we hope that by releasing the source code used in our experiments, we can inspire other researchers to build on our work and try out new applications we havent even dreamed of.

The release of the FermiNet code comes after DeepMind demonstrated its work on an AI system that can predict the movement of glass molecules as they transition between liquid and solid states. (Both the techniques and trained models, which were also made available in open source, could be used to predict other qualities of interest in glass, DeepMind said.) Beyond glass, the researchers asserted the work yielded insights into general substance and biological transitions, and that it could lead to advances in industries like manufacturing and medicine.

Read this article:

DeepMind open-sources the FermiNet, a neural network that simulates electron behaviors - VentureBeat

Read the Rest...

Brazil Complementary and Alternative Medicine Market Industry Size, Share, Market Dynamics, Emerging Trends and Forecast (2020 2026) – re:Jerusalem

§ October 19th, 2020 § Filed under Quantum Medicine Comments Off on Brazil Complementary and Alternative Medicine Market Industry Size, Share, Market Dynamics, Emerging Trends and Forecast (2020 2026) – re:Jerusalem

Facts & Factors (FnF),a leading market research company recently published a research report onResearch Report on Brazil Complementary and Alternative Medicine Market Size & Share 2020 Covering COVID-19 Impact Analysis and Forecast to 2026to its research database. This[190+] PDF pages Brazil Complementary and Alternative Medicine Marketreport analyzes the comprehensive overview of the market comprising an executive summary that covers core trends evolving in the market.

Brazil Complementary and Alternative Medicine Market 2020 Overview and Deliverables

The global Brazil Complementary and Alternative Medicine market research report delivers an in-depth well-organized perspective of the information associated with theBrazil Complementary and Alternative Medicine market. Several key market contenders have to face challenging situations to hold a significant market share in the global Brazil Complementary and Alternative Medicine market, which includes industries, production plants, firms, and vendors. In order to be at the leading position, the key player has to reach ahead of others in terms of production, sales, quality, better services, and revenue generation.

The global Brazil Complementary and Alternative Medicine market report represents the markets data in a better-analyzed way by fragmenting the market in several key segments. The global Brazil Complementary and Alternative Medicine market research report involves a comprehensive study of different factors influencing the market growth. Along with this, novel technological advancements, a complete profile of key market players ruling the global and regional Brazil Complementary and Alternative Medicine market are also comprised in the report.

Request an Exclusive Free Sample Report of Brazil Complementary and Alternative Medicine Market:https://www.fnfresearch.com/sample/brazil-complementary-and-alternative-medicine-market-by-type-111

(The sample of this report is readily available on request).

The FREE PDF Sample Report Includes:

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Some of Following Top Market Players Profile Included in This Report:

Interested to Know the Full List of Companies Covered in This Report? Use this Link:https://www.fnfresearch.com/sample/brazil-complementary-and-alternative-medicine-market-by-type-111

What Does This Research Report Cover?

The global Brazil Complementary and Alternative Medicine market sizereport provides detailed information about the Brazil Complementary and Alternative Medicine market with an appropriate examination of several parameters and trends influencing its development on a global basis. Based on the examination of influencing growth and limiting parameters, the precise data indicating the future growth trend of the market can be obtained, which is thoroughly explained in the Brazil Complementary and Alternative Medicine market research report. The information regarding the approaching opportunities that can boost the market capitalization is also included in the report. The report also comprises essential information such as annual revenue generation, market value, expenditure, yearly sales, and other important statistical data, regarding the key market contenders which include several organizations, firms, product manufacturers, vendors, and distributors.

The global Brazil Complementary and Alternative Medicine market research report bifurcates the market into different segments in order to better analyze the Brazil Complementary and Alternative Medicine market. The global Brazil Complementary and Alternative Medicine market report delivers precise investigative information about the varying cutthroat dynamics. A predictable growth trend to be followed by the Brazil Complementary and Alternative Medicine market is also included in the report.

How COVID-19 Pandemic Impact Brazil Complementary and Alternative Medicine Market Growth?

The raise of COVID-19 has many businesses struggling and confused about what steps to take to minimize the economic impact. A simple look at the stock market will tell you that coronavirus has led to a volatile economy, but there are numerous other factors at play.

The long-term COVID-19 impact on the business industry is largely still unknown; hence,Facts and Factors market researchanalysts have already covered the effects of COVID-19 on the business industry at a large level, as well as and regional level. Through our coverage below, get a better understanding of the business and economic implications coronavirus has on trends like remote working, consumer shopping behavior, advertising spend, and essential industries like food, medical, travel, and transportation.

Request a Link for Free PDF Brochure covering COVID-19 Pandemic Business Impact on Brazil Complementary and Alternative Medicine Market:https://www.fnfresearch.com/sample/brazil-complementary-and-alternative-medicine-market-by-type-111

Global Brazil Complementary and Alternative Medicine Market Regional Analysis and Key Segments

The global analysis of the markets data is a tough task; so, for ease of understanding and better recognition of market trends, the globalBrazil Complementary and Alternative Medicine market sizereport delivers the information at a regional or geographical level. The report also enlightens the possible impact of administrative laws and policies on the market growth are included in the report. Keeping the above-mentioned factors into consideration along with the past and current situation of the market, the team of professional analysts has generated a predictable market trend to be followed by the market for several upcoming years.

Additionally, the report comprises the overall business chain, through which the growth rate and deterioration rate of the specific industry in the market can be analyzed. The total cost spent on manufacturing the product and analysis of its assembling procedure is also described in the report.

Along with this, the global Brazil Complementary and Alternative Medicine market report also provides the discussion over the market economy regarding the total revenue generation by the market at the global level, along with the manufacturing techniques and cost, demand, and supply of a generated product or offered services, capacity, consumption, and other related information.

Need Customization? Request a Customized Copy of This Report:https://www.fnfresearch.com/customization/brazil-complementary-and-alternative-medicine-market-by-type-111

(We customize your report according to your research need. Ask our sales team for report customization.)

The Brazil Complementary and Alternative Medicine report is an inclusive study of the market, which provides sufficient knowledge to the clients for efficient decision-making with the aim of expanding business considerably in the market. With the help of statistical graphs, figures, flow charts, and real examples, the report represents the analytical data in an efficient way, which would be easily understandable for the readers even by going through the report.

Read Detail Research Report for More Information:https://www.fnfresearch.com/brazil-complementary-and-alternative-medicine-market-by-type-111

What this Brazil Complementary and Alternative Medicine Market research report offers:

1. Global Brazil Complementary and Alternative Medicine Market size, share assessments for the regional and country-level segments.

2. Global market Trends, Drivers, Constraints, Growth Opportunities, Threats, Challenges, Investment Opportunities, and recommendations.

3. Brazil Complementary and Alternative Medicine Market forecasts for 5 years along with historical data of all the mentioned segments, sub-segments, and the regional markets.

4. Competitive landscaping mapping the key trends.

5. Major company profiling with their detailed strategies, financials, and recent developments.

6. Strategic recommendations for new companies and startups.

8. Supply chain trends mapping the latest technological advancements.

9. Strategic recommendations in business segments based on market estimations.

About Us:

Facts & Factorsis a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our clients/customers conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them inappropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email:sales@fnfresearch.com

Web:https://www.fnfresearch.com

Follow this link:

Brazil Complementary and Alternative Medicine Market Industry Size, Share, Market Dynamics, Emerging Trends and Forecast (2020 2026) - re:Jerusalem

Read the Rest...

Trump has shown little respect for U.S. science. So why are some parts thriving? – Science Magazine

§ October 17th, 2020 § Filed under Quantum Medicine Comments Off on Trump has shown little respect for U.S. science. So why are some parts thriving? – Science Magazine

By Jeffrey MervisOct. 14, 2020 , 1:30 PM

Disastrous. Damaging. Catastrophic. Those are just some of the more polite terms that many U.S. scientists use to describe the policies of President Donald Trump. His handling of the COVID-19 pandemic, his repeated public dismissals of scientific expertise, and his disdain for evidence have prompted many researchers to label him the most antiscience president in living memory.

Last month, that sense of betrayal led two of the nations preeminent scientific bodies, the U.S. National Academy of Sciences and the National Academy of Medicine, to issue an uncharacteristically harsh rebuke. Although the 24 September statement did not name Trump, it was clearly aimed at the president.

Policymaking must be informed by the best available evidence without it being distorted, concealed, or otherwise deliberately miscommunicated, the leaders of the two academies wrote. We find reports and incidents of the politicization of science, particularly the overriding of evidence and advice from public health officials and derision of government scientists, to be alarming.

Although many U.S. scientists share those sentiments, other aspects of the administrations overall record elicit a more positive response. Ask researchers how federal funding for their fields has fared since Trump took office in January 2017, and they might acknowledge sustained support and even mention new opportunities in some areas. Inquire about what they think of the appointees leading the federal agencies that fund their work, and they will offer some goodeven glowingreviews.

Those seemingly contradictory responses reflect the complexity of an $80-billion-a-year system that remains the envy of the world. Any president trying to alter that behemoth has three levers to presspolicies, budget requests, and leadership appointments.

To analyze Trumps record in each area, Science has talked to dozens of researchers, administrators, and lobbyists. Many asked to remain anonymous because they have ongoing interactions with the administration.

Most scientists give Trump exceedingly low marks in an arena where he has perhaps the greatest authority: foreign affairs. His unilateral decisions to pull out of the Paris climate treaty, the Iran nuclear deal, and the World Health Organization are widely seen as damaging not just to global scientific cooperation, but also to the continued health, safety, and prosperity of the planet. Similarly, most scientists think the administrations aggressive efforts to restrict immigration pose a serious threat to the nations ability to attract scientific talent from around the world.

President Donald Trump has often ignored advice from experts, such as the National Institutes of Healths AnthonyFauci, on how to address the COVID-19 pandemic.

In the domestic arena, Trumps efforts to impose new policies by executive order and rewrite regulations have also drawn sharp criticism from scientists. They say the administration has routinely ignored or suppressed evidence that doesnt support its efforts to roll back environmental regulations, including those aimed at limiting emissions of greenhouse gases. Trump has also threatened the reliability of key demographic data by interfering with the orderly completion of the 2020 census, and by telling the Department of Commerce to exclude undocumented residents from the final count.

Biomedical researchers, meanwhile, have been appalled by what they say is a de facto ban on the use of tissue derived from elective abortions in research, as well as orders to cancel a grant that Trump disliked. Such moves, many researchers believe, are designed to advance the presidents political agenda at the expense of national interests.

Fewer scientists complain about the Trump administrations record on spending. But thats largely because Congress has ignored the deep cuts the White House has proposed in its annual budget requests to Congress (see graphic, below).

For example, the National Institutes of Health (NIH), the biggest federal supporter of academic research, has seen its budget rise by 39% in the past 5 years despite deep cuts proposed by Trump. The budget of the National Science Foundation (NSF) has gone up by 17% over the past 3 years, reversing the downward direction that Trump has requested and rising more than twice as fast as it did under former President Barack Obama.

Researchers working on artificial intelligence (AI) and in quantum information science are enjoying an even more rapid growth rate. In a rare embrace of large spending increases, the Trump administration has thrown its weight behind a 2-year doubling of those fields, which fuel what it calls industries of the future. And Congress seems amenable to the idea.

Assessing the presidents appointees is more complicated. Scientists have condemned some of Trumps choices at agencies involved in environmental regulation or climate science, citing their meager scientific credentials or views that are outside the mainstream. The appointees are clustered at the Environmental Protection Agency (EPA), the National Oceanic and Atmospheric Administration (NOAA), and the Department of the Interior. The list also includes three recently installed senior officials at the Census Bureau, which is embroiled in controversy over its plans for completing the 2020 census.

At the same time, most scientists give high marks to the officials who lead agencies that hand out the bulk of federal research dollars (and are generally not involved in hot-button regulatory issues). That list includes the heads of NIHObama-era holdover Francis Collinsand NSF, where Sethuraman Panchanathan succeeded Obama appointee France Crdova after her 6-year term ended in March. Physical scientists also give good reviews to Paul Dabbar and Chris Fall, who manage the science portfolio at the Department of Energy (DOE).

A third group of Trump science appointees remains something of an enigma to the U.S. research community. They include the presidents unofficial science adviser, Kelvin Droegemeier; Robert Redfield, head of the Centers for Disease Control and Prevention; and Stephen Hahn, head of the Food and Drug Administration.

The trio are considered able scientists and are generally respected by their peers. But Droegemeier, who leads the White House Office of Science and Technology Policy (OSTP), has disappointed many science policy insiders by failing to make good on promises to better coordinate federal policies that affect universities. I give him an A for effort, and an F for performance, one observer says. And all three leaders have drawn complaints for their tepid responses when Trump has disputed settled science or attacked their agencies and the scientists who work for them.

But such broad strokes paint only a partial picture of how Trump has influenced the U.S. research enterprise. Below,Sciencelooks at how federal science agencies have fared under a president who has repeatedly boasted of draining the swamp in the nations capital.

Trumps arrival brought fears of upheaval, but NIH watchers say the agency has managed to stay on course. Collinss warm relationship with congressional leaders has helped win generous budget increases. And Ned Sharpless, Trumps choice to lead its largest institute, the National Cancer Institute, has been fantastic, says Jon Retzlaff, chief policy officer for the American Association for Cancer Research.

In contrast, researchers say White House pressure caused NIH to launch a damaging crackdown on scientists with foreign ties (see below). They also accuse Trump of political meddling in two important issuesfetal tissue research and pandemic research. In June 2019, the White House ended funding for NIHs in-house research using tissue from elective abortions and announced a new ethics review for extramural grants. This year, a 15-member ethics panel dominated by abortion opponents recommended approval of only one of 14 proposals that had passed review. And in April, NIH pulled a grant to the EcoHealth Alliance, a nonprofit organization working on bat viruses with the Chinese group that Trump accusedwithout evidenceof releasing the SARS-CoV-2 virus driving the pandemic.

Those actions have sent a chilling message to scientists, says molecular biologist Keith Yamamoto of the University of California, San Francisco. If problems that you have a real passion to dig into are deemed politically unsound, you could be out of luck. So watch out.

Arriving 2 years into Trumps 4-year term to head OSTP, Droegemeier promised to streamline and improve how the federal government manages academic research. But an interagency panel he created to take on the taskthe Joint Committee on the Research Environment (JCORE)has yet to reach consensus on any of the four areas Droegemeier has targeted.

He came in all fired up, promising to make things happen, one lobbyist says. But so far nothing has come out of JCORE, and the research community is very disappointed.

Research advocates do praise OSTP for helping focus more attention on AI and quantum information science. But science lobbyists say the real driver of that initiative has been Michael Kratsios, a scientific neophyte who was nominally in charge of OSTP before Droegemeier joined the administration.

Kratsios came into the job knowing less about science than any previous OSTP head, one university lobbyist says. But he was eager to learn, and he listens. Hes also figured out how to use his connections to advance the administrations agenda.

President Donald Trump has repeatedly asked Congress to approve deep spending cuts at most federal research agencies. But lawmakers have generally ignored his requests and have typically boosted science budgetswith some agencies getting hefty increases.

21.5% 11% 3.9% 17.1% 16.1% 7.9% 0.9% 6.7% 5.8% 6.3% 5% 13% 44% 9.7% 31.9% 6.8% 3.8% 13.9% 5.2% 41.4% 25.1% 40% 21% 11.7% 0% 0% 0% 12% 11% 5.2% 4% 5.4% 3.2% 1.1% 12.6% 12.5% 15.8% 7.4% 40.8% 15.3% 3.8% 0.9% 4.3% 3.4% 6.3% 2.5% 6.5% 9.5% 34% 16% 4% 1% 15% 8.7% Trump request Final appropriation NIH NSF DOE Science NASA Science NOAA Science USGS* DARPA* EPA S&T* NIST Labs* *U.S. Geological Survey (USGS), Defense Advanced Research Projects Agency (DARPA), Environmental Protection Agency Science & Technology (EPA S&T), National Institute of Standards and Technology (NIST Labs) 2018 2019 2020

(GRAPHIC) N. DESAI/SCIENCE; (DATA) AAAS/R&D BUDGET AND POLICY PROGRAM

Trumps first energy secretary, Rick Perry, had vowed to eliminate DOE when he ran against Trump in 2016. But Perry surprised the community by becoming a champion of the departments science mission, and his successor, Dan Brouillette, has embraced that role since taking over in December 2019. Observers also credit undersecretary Dabbar for sustaining the political momentum behind several big projects at DOEs 17 national laboratories, including a new atom smasher to study nuclear physics at Brookhaven National Laboratory and a fast-neutron test reactor at Idaho National Laboratory.

Despite the Trump administrations distaste for clean energy research and its conviction that private industry is the real engine of innovation, DOEs $7 billion Office of Science has fared well. It benefited handsomely from the administrations embrace of AI and quantum information science, where physicists and engineers try to leverage subtle quantum effects to develop more powerful supercomputers and secure communication systems. In July, for example, DOE announced it would build a prototype quantum network to connect Argonne National Laboratory, Fermi National Accelerator Laboratory, and the University of Chicago.

Fall, who was already working for the government when he became head of DOEs basic science shop in May 2019, thinks his office has thrived by avoiding ideological battles over the proper role of government in creating new technologies. What we dont do is policy, he says. Im doing my level best to keep the Office of Science out of politics.

Given candidate Trumps rhetoric opposing government regulation, his affection for fossil fuels, and his denial of climate change, its no surprise that EPA has often disregarded science in devising environmental policy. Its approach to regulating particulate air pollutionoften called PM2.5 (particulate matter smaller than 2.5 microns in diameter)contains all the hallmarks of that approach, including appointing people tied to polluting industries to key posts, excluding experts from advisory roles, and using questionable methods to tip the scales when balancing benefits against costs.

Soon after his appointment in 2017, thenEPA Administrator Scott Pruitt launched several major changes that would likely help ease regulations of PM2.5, which is linked to increased heart and lung diseases and premature deaths. He banned any EPA-funded scientist from serving on advisory boards that vet proposed regulations, but kept the door open to people associated with polluting industries. (A federal court overturned the ban earlier this year.) Pruitt also installed an industry consultant, Tony Cox, as chairman of the air pollution science committee and abolished an expert panel, led by Christopher Frey of North Carolina State University, that advised the committee on the science of particulate matter.

Although Pruitt was forced out of the agency in mid-2018, his replacement, Andrew Wheeler, has followed a similar path. He declined a recommendation from agency scientists to tighten PM2.5 limits, citing a study by the reconstituted committee that found the science behind such a reduction was uncertain. The agencys recent actions just made the whole thing a charade, Frey says.

EPA officials have also proposed barring the agency from considering certain scientific studies as it develops regulations if the underlying data cannot be made public because of concerns about patient privacy or trade secrets. Thats the case for some large studies on how air pollution affects public health, and for many industry-funded reviews of toxic chemicals. Researchers say the rule fails to recognize the legitimate need to protect the confidentiality of some data and will undermine the quality of EPAs rulemaking.

Home to some of the countrys premier climate scientists, NOAA managed to operate mostly under the radar until August 2019, when Trump announced erroneously that Hurricane Dorian posed a threat to the state of Alabama and apparently used a marker to alter a National Weather Service forecast showing its path. The White House and Commerce Department pushed NOAAs acting administrator, Neil Jacobs, to reprimand weather forecasters for their correction of the presidents map and tweets. That political flap, dubbed Sharpiegate, ultimately led to the arrival last month of two new senior political appointees, David Legates and Ryan Maue, who have been dismissive of climate science.

I have grave concerns around these appointments, says Jonathan White, a retired Navy admiral and CEO of the Consortium for Ocean Leadership. NOAA has the best [climate] scientists in the government, and Im very concerned these voices will be muzzled.

A hurricane forecast map altered with a marker touched off controversy in September 2019.

As custodian for more than 1.8 million square kilometers of federal land, the Department of the Interior has been a central player in the Trump administrations push for more oil and gas drilling. But critics say department officials have often overlooked, disregarded, or altered the relevant science, enabling them to dismiss the climate impacts of that drilling and discount potential harm to endangered species.

One early target was calculations of the economic toll from greenhouse gas emissions. Shortly after Trump took office, the department drastically reduced estimates by the Obama administration of such costs. It did so by considering only direct impacts in the United States and by reducing the dollar value of impacts on future generations.

The Trump administration has used the lower price tags to justify rolling back Obama-era limits on methane emissions from oil and gas wells, as well as carbon dioxide from cars and power plants, which fall under the authority of the Department of Transportation and EPA, respectively. But this year, a federal judge ruled the lower estimates were not defensible and that the Interior Department had tried to erase the scientific and economic facts used in the previous estimates.

The plight of endangered species has received little attention during the Trump administration, with the number of new species being listed for federal protection at an all-time low. The Fish and Wildlife Service, the branch of the Interior Department that decides whether a species is endangered, just doesnt have the institutional support to really push back when politics gets in the way of science, says Brett Hartl of the Center for Biological Diversity, which frequently sues federal agencies over endangered species. Theyre kind of a forgotten agency.

Agriculture Secretary Sonny Perdue upset scientists with his decision to move two of the agencys research centersthe National Institute of Food and Agriculture (NIFA) and the Economic Research Service (ERS)from Washington, D.C., to Kansas City, Missouri. According to the Congressional Research Service, roughly 75% of the employees left the Department of Agriculture (USDA) rather than move, and many grants were delayed by several months.

Perdue said the new location would bring NIFA and ERS closer to their constituencies and save on rent. But many observersincluding congressional Democratssaw the move as an excuse to shrink ERS and diminish its ability to provide objective monitoring of myriad agricultural trends through its surveys and reports. And they worried the departures of so many veteran staff would deprive USDA of institutional knowledge and expertise that would take years to replace.

On the plus side, USDAs decision this year to exempt certain gene-edited crops from its biotechnology regulations, potentially easing research, has been well received, says Karl Anderson, director of government relations for the American Society of Agronomy, the Crop Science Society of America, and the Soil Science Society of America. Anderson also applauds the agencys first ever set of long-range goals, which aim to increase agricultural production by 40% by 2050 while cutting the industrys environmental footprint in half. I think its a terrific effort, he says.

The Trump administrations efforts to limit or prohibit scientific collaborations with China and other countries deemed to pose national security risks have set off alarms throughout the academic community. Although separate from the presidents attempts to restrict immigration, both efforts run counter to the traditionally open environment that has propelled U.S. science since the end of World War II. Many researchers also regard them as exercises in racial and ethnic stereotyping.

The Obama administration pursued a handful of investigations, some later dropped, involving scientists with ties to China. But in the summer of 2018, NIH began to send letters to dozens of universities flagging nearly 200 faculty members believed to have hidden research support from Chinese entities. At the same time, university leaders heard themselves being accused of unwittingly handing over the fruits of federally funded research to China, the United Statess chief rival as a scientific and economic superpower.

Trump joined Middle Eastern leaders in 2017 at a new institute in Saudi Arabia studying terrorist threats.

In November 2018, the Department of Justice announced its China Initiative, making it clear that NIHs investigations were part of a broader campaign. Several scientists have been indicted and some have pleaded guilty, although the charges typically involve making false statements to federal officials or covering up their foreign ties rather than passing along sensitive technologies.

Several agencies have taken steps aimed at learning who else is funding research by their grantees and then deciding whether those other sources pose a threat to national security. But NIHs actions are widely regarded as the most aggressive and, thus, potentially the most harmful. NSF, for example, insists on full disclosure but only occasionally initiates an investigation, and DOE has told its own scientists they cannot participate in foreign talent recruitment programs but has not altered its rules for grantees.

Agencies are under tremendous pressure from the White House to find guilty people, says Stanford University physicist Steven Chu, a Nobel Prize winner and former energy secretary under Obama (and a past president of AAAS,Sciences publisher). NSF has tried to push back, but NIH has almost completely folded.

The country needs to defend itself against military and economic espionage, scientists say, but some worry the administrations actions to date have already damaged the U.S. research enterprise and that additional restrictions could be fatal.

The potential loss is hard to estimate, Chu says. Noting the outsize contribution of foreign-born scientists to U.S. technical innovation in the past 30 years, he adds, Its scary to think [what would happen] if you shut that off.

Looking ahead to such research-based challenges as the COVID-19 pandemic and climate change, many scientists crave leadership that respects science. On 2 September, for example, 81 Nobel laureates announced their support for Trumps opponent, Democrat Joe Biden. (So far, Trump has not received such an endorsement, although there was a Scientists for Trump group during the 2016 contest.)

In their letter, the laureates dont mention any specific policies that Biden has championed over nearly a half-century in public office, including his 8 years as vice president under Obama. But the statement makes clear that they think a Biden administration will do a better job of interacting with the scientific community.

At no time in our nations history has there been a greater need for our leaders to appreciate the value of science in formulating public policy, they write in a public letter. Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaborations in research, and his respect for the contribution that immigrants make to the intellectual life of our country.

More than a political endorsement, the letter reflects a sense that the federal government has turned its back on science in the past 4 years and their hope that the next president will, in Obamas memorable phrase, restore science to its rightful place.

With reporting by Adrian Cho, Warren Cornwall, Jocelyn Kaiser, Robert F. Service, Erik Stokstad, and Paul Voosen.

More here:

Trump has shown little respect for U.S. science. So why are some parts thriving? - Science Magazine

Read the Rest...

The Week of October 12, 2020 – FYI: Science Policy News

§ October 14th, 2020 § Filed under Quantum Medicine Comments Off on The Week of October 12, 2020 – FYI: Science Policy News

Research Groups Seek Rollback of Diversity TrainingRestrictions

A Sept. 22 executive order restricting certain kinds of diversity and inclusion training has created confusion for universities and federal contractors, spurring some institutions to suspendtraining programs and postpone planned events. Federal agencies have also been instructed to suspend all diversity training programs pending a review of compliance with the order. Dozens of higher education associations sent a letter to President Trump last week requesting he withdraw the order, saying it has a chilling effect on campus efforts to ensure non-discriminatory workplaces and requires an unprecedented expansive review of internal training materials at both public and private entities. Separately, 50 scientific societies, including AIP, sent a letter to the White House last week denouncing the order, arguing it wrongfully insinuates that certain trainings are inherently anti-American and "sends a message of division, intolerance, and subjectivity that is damaging to our R&D community.

On Oct. 8, the New England Journal of Medicine published an editorial blasting the U.S. response to the COVID-19 pandemic and, while not mentioning President Trump specifically, appealed to voters to cast out current federal government leaders. Calling them dangerously incompetent, the editorial argues those leaders have undercut trust in science and in government, causing damage that will certainly outlast them. The top-tier medical journal has not previously made such an exhortation to voters in its 208 year history. On Oct. 5, the United Kingdom-based journal Nature published a news feature surveying ways the Trump administration has damaged science, touching on issues such as the pandemic response, climate change, environmental regulation, and immigration policy. Citing policy experts, the article also reports that the administration has, across agencies, undermined scientific integrity by suppressing or distorting evidence to support political decisions. The journal has not taken an editorial position on the election, but its editors also announced last week that they plan to increase coverage of global politics and publish more political science research, partly due tosigns that politicians around the world are pushing back against the principle of protecting scholarly autonomy, or academic freedom. The two journals are the latest prestigious science publications to cast Trump as corrosive to science and science-informed policy. In recent weeks, the editor-in-chief of Science has excoriated Trump for lying about the pandemic, while Scientific American made its first-ever presidential endorsement, backing Democratic candidate Joe Biden. (Update: Nature has since endorsed Biden.)

On Oct. 2, former National Oceanic and Atmospheric Administration heads Conrad Lautenbacher and Jane Lubchenco wrote to the agency on behalf of an ocean policy advocacy group, expressing alarm over the recent appointments of climatologist David Legates and meteorologist Ryan Maue to high-level positions there. The appointments have attracted criticism because Legates and Maue have often dismissed mainstream views about the severity of anthropogenic climate change, and E&E News has reported the Trump administration expects its new appointees to influence the agencys work on climate and the next interagency National Climate Assessment. Lautenbacher and Lubchenco led NOAA during the administrations of Presidents George W. Bush and Barack Obama, respectively, and while Lubchenco has often protested Trump administration actions, Lautenbacher has been more reserved. Justifying their intervention, the two wrote, We cannot be silent on this we are concerned that the freedom of NOAA scientists to communicate honestly and openly about the impacts of climate change, the future of honest and accurate weather forecasting, objective fisheries management, disaster response, and much more will be further curtailed if these appointments go forward.

The Departments of Labor and Homeland Security issued rules last week that together increase the wages employers must offer workers seeking H-1B visas and require the applicants degree to more closely match their job category, among other changes. Both departments cite the increased unemployment caused by COVID-19 as justification for the rules taking effect immediately without a public notice and comment period. The H-1B visa program is used by many technology companies and universities to hire workers in STEM fields, but it has come under criticism in recent years that is largely focused on alleged abuses of the program by certain information technology companies. President Trump has already suspended issuance of H-1B visas through the end of the year, though a federal judge partially blocked the policy on Oct. 1.

The House Intelligence Subcommittee on Strategic Technologies and Advanced Research released a report last week recommending ways the U.S. can maintain a leading role in developing emerging technologies such as artificial intelligence, quantum computing, and biotechnology. Among its proposals, the report calls for the federal government to expand spending on basic research and couple those investments with changes to how the intelligence community organizes, establishes relationships, and sets priorities for R&D. The report also argues that the emphasis often placed on competition with China represents an overly narrow view, and stresses that the subcommittees recommendations are generally not calls for the hierarchy, direction, and centralized control that characterize Chinese innovation efforts [and instead] reflect the ideas of openness, flexibility and agility that gave rise to American innovative success from Los Alamos to Silicon Valley. The reportrecommends a number of moves to bolster the intelligence community workforce, including by creating a STEM fellowship program and reforming U.S. immigration policies. Subcommittee Chair Jim Himes (D-CT) is discussing the report at an event on Thursday.

Last week, the National Quantum Coordination Office rolled out its official logo and website quantum.gov, which collects strategy documents and updates about the National Quantum Initiative. The office also released a report summarizing frontier research areas in quantum information science and announced the inaugural meeting of the National Q12 Education Partnership, an effort to introduce students to QIS concepts at earlier grade levels. The White House established the coordination office last year, as required by the National Quantum Initiative Act, to keep tabs on the governments growing portfolio of QIS research centers and workforce development efforts. The office is led by physicist Charles Tahan, who is on detail from the National Security Agencys Laboratory for Physical Sciences, where he is chief scientist. Tahan also serves as co-chair of the newly established National Quantum Initiative Advisory Committee, which is holding its first meeting on Oct. 27.

Read more from the original source:

The Week of October 12, 2020 - FYI: Science Policy News

Read the Rest...

Complementary and Alternative Medicine Market Provides An In-Depth Insight Of Sales And Trends, Forecast To 2026 | Columbia Nutritional, Herb Pharm,…

§ October 9th, 2020 § Filed under Quantum Medicine Comments Off on Complementary and Alternative Medicine Market Provides An In-Depth Insight Of Sales And Trends, Forecast To 2026 | Columbia Nutritional, Herb Pharm,…

LOS ANGELES, United States:The report titledGlobal Complementary and Alternative Medicine Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Complementary and Alternative Medicine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Complementary and Alternative Medicine market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Complementary and Alternative Medicine market is carefully analyzed and researched about by the market analysts.The market analysts and researchers have done extensive analysis of the global Complementary and Alternative Medicine market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Complementary and Alternative Medicine report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

In addition, market revenues based on region and country are provided in the Complementary and Alternative Medicine report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Complementary and Alternative Medicine market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Complementary and Alternative Medicine market are mapped by the report. With the help of this report, the key players of the global Complementary and Alternative Medicine market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Complementary and Alternative Medicine market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Complementary and Alternative Medicine market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global Complementary and Alternative Medicine Market Research Report: , Columbia Nutritional, Herb Pharm, Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, Quantum Touch Complementary and Alternative Medicine

Complementary and Alternative Medicine Market Types: , Botanicals, Acupuncture, Mind, Body, and Yoga, Magnetic Intervention Complementary and Alternative Medicine

Complementary and Alternative Medicine Market Applications: Direct Contact, E-training, Distance Correspondence

The Complementary and Alternative Medicine Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Complementary and Alternative Medicine market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Complementary and Alternative Medicine market and its potential to grow in the years to come.

Key questions answered in the report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

Table of Contents:

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Complementary and Alternative Medicine Revenue 1.4 Market Analysis by Type

1.4.1 Global Complementary and Alternative Medicine Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Botanicals

1.4.3 Acupuncture

1.4.4 Mind, Body, and Yoga

1.4.5 Magnetic Intervention 1.5 Market by Application

1.5.1 Global Complementary and Alternative Medicine Market Share by Application: 2020 VS 2026

1.5.2 Direct Contact

1.5.3 E-training

1.5.4 Distance Correspondence 1.6 Coronavirus Disease 2019 (Covid-19): Complementary and Alternative Medicine Industry Impact

1.6.1 How the Covid-19 is Affecting the Complementary and Alternative Medicine Industry

1.6.1.1 Complementary and Alternative Medicine Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Complementary and Alternative Medicine Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Complementary and Alternative Medicine Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Complementary and Alternative Medicine Market Perspective (2015-2026) 2.2 Complementary and Alternative Medicine Growth Trends by Regions

2.2.1 Complementary and Alternative Medicine Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Complementary and Alternative Medicine Historic Market Share by Regions (2015-2020)

2.2.3 Complementary and Alternative Medicine Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porters Five Forces Analysis

2.3.5 Complementary and Alternative Medicine Market Growth Strategy

2.3.6 Primary Interviews with Key Complementary and Alternative Medicine Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Complementary and Alternative Medicine Players by Market Size

3.1.1 Global Top Complementary and Alternative Medicine Players by Revenue (2015-2020)

3.1.2 Global Complementary and Alternative Medicine Revenue Market Share by Players (2015-2020)

3.1.3 Global Complementary and Alternative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Complementary and Alternative Medicine Market Concentration Ratio

3.2.1 Global Complementary and Alternative Medicine Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Complementary and Alternative Medicine Revenue in 2019 3.3 Complementary and Alternative Medicine Key Players Head office and Area Served 3.4 Key Players Complementary and Alternative Medicine Product Solution and Service 3.5 Date of Enter into Complementary and Alternative Medicine Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Complementary and Alternative Medicine Historic Market Size by Type (2015-2020) 4.2 Global Complementary and Alternative Medicine Forecasted Market Size by Type (2021-2026) 5 Complementary and Alternative Medicine Breakdown Data by Application (2015-2026) 5.1 Global Complementary and Alternative Medicine Market Size by Application (2015-2020) 5.2 Global Complementary and Alternative Medicine Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Complementary and Alternative Medicine Market Size (2015-2020) 6.2 Complementary and Alternative Medicine Key Players in North America (2019-2020) 6.3 North America Complementary and Alternative Medicine Market Size by Type (2015-2020) 6.4 North America Complementary and Alternative Medicine Market Size by Application (2015-2020) 7 Europe 7.1 Europe Complementary and Alternative Medicine Market Size (2015-2020) 7.2 Complementary and Alternative Medicine Key Players in Europe (2019-2020) 7.3 Europe Complementary and Alternative Medicine Market Size by Type (2015-2020) 7.4 Europe Complementary and Alternative Medicine Market Size by Application (2015-2020) 8 China 8.1 China Complementary and Alternative Medicine Market Size (2015-2020) 8.2 Complementary and Alternative Medicine Key Players in China (2019-2020) 8.3 China Complementary and Alternative Medicine Market Size by Type (2015-2020) 8.4 China Complementary and Alternative Medicine Market Size by Application (2015-2020) 9 Japan 9.1 Japan Complementary and Alternative Medicine Market Size (2015-2020) 9.2 Complementary and Alternative Medicine Key Players in Japan (2019-2020) 9.3 Japan Complementary and Alternative Medicine Market Size by Type (2015-2020) 9.4 Japan Complementary and Alternative Medicine Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Complementary and Alternative Medicine Market Size (2015-2020) 10.2 Complementary and Alternative Medicine Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Complementary and Alternative Medicine Market Size by Type (2015-2020) 10.4 Southeast Asia Complementary and Alternative Medicine Market Size by Application (2015-2020) 11 India 11.1 India Complementary and Alternative Medicine Market Size (2015-2020) 11.2 Complementary and Alternative Medicine Key Players in India (2019-2020) 11.3 India Complementary and Alternative Medicine Market Size by Type (2015-2020) 11.4 India Complementary and Alternative Medicine Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Complementary and Alternative Medicine Market Size (2015-2020) 12.2 Complementary and Alternative Medicine Key Players in Central & South America (2019-2020) 12.3 Central & South America Complementary and Alternative Medicine Market Size by Type (2015-2020) 12.4 Central & South America Complementary and Alternative Medicine Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Columbia Nutritional

13.1.1 Columbia Nutritional Company Details

13.1.2 Columbia Nutritional Business Overview and Its Total Revenue

13.1.3 Columbia Nutritional Complementary and Alternative Medicine Introduction

13.1.4 Columbia Nutritional Revenue in Complementary and Alternative Medicine Business (2015-2020))

13.1.5 Columbia Nutritional Recent Development 13.2 Herb Pharm

13.2.1 Herb Pharm Company Details

13.2.2 Herb Pharm Business Overview and Its Total Revenue

13.2.3 Herb Pharm Complementary and Alternative Medicine Introduction

13.2.4 Herb Pharm Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.2.5 Herb Pharm Recent Development 13.3 Herbal Hills

13.3.1 Herbal Hills Company Details

13.3.2 Herbal Hills Business Overview and Its Total Revenue

13.3.3 Herbal Hills Complementary and Alternative Medicine Introduction

13.3.4 Herbal Hills Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.3.5 Herbal Hills Recent Development 13.4 Helio USA

13.4.1 Helio USA Company Details

13.4.2 Helio USA Business Overview and Its Total Revenue

13.4.3 Helio USA Complementary and Alternative Medicine Introduction

13.4.4 Helio USA Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.4.5 Helio USA Recent Development 13.5 Deepure Plus

13.5.1 Deepure Plus Company Details

13.5.2 Deepure Plus Business Overview and Its Total Revenue

13.5.3 Deepure Plus Complementary and Alternative Medicine Introduction

13.5.4 Deepure Plus Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.5.5 Deepure Plus Recent Development 13.6 Nordic Naturals

13.6.1 Nordic Naturals Company Details

13.6.2 Nordic Naturals Business Overview and Its Total Revenue

13.6.3 Nordic Naturals Complementary and Alternative Medicine Introduction

13.6.4 Nordic Naturals Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.6.5 Nordic Naturals Recent Development 13.7 Pure encapsulations

13.7.1 Pure encapsulations Company Details

13.7.2 Pure encapsulations Business Overview and Its Total Revenue

13.7.3 Pure encapsulations Complementary and Alternative Medicine Introduction

13.7.4 Pure encapsulations Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.7.5 Pure encapsulations Recent Development 13.8 Iyengar Yoga Institute

13.8.1 Iyengar Yoga Institute Company Details

13.8.2 Iyengar Yoga Institute Business Overview and Its Total Revenue

13.8.3 Iyengar Yoga Institute Complementary and Alternative Medicine Introduction

13.8.4 Iyengar Yoga Institute Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.8.5 Iyengar Yoga Institute Recent Development 13.9 John Schumachers Unity Woods Yoga Center

13.9.1 John Schumachers Unity Woods Yoga Center Company Details

13.9.2 John Schumachers Unity Woods Yoga Center Business Overview and Its Total Revenue

13.9.3 John Schumachers Unity Woods Yoga Center Complementary and Alternative Medicine Introduction

13.9.4 John Schumachers Unity Woods Yoga Center Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.9.5 John Schumachers Unity Woods Yoga Center Recent Development 13.10 Yoga Tree

13.10.1 Yoga Tree Company Details

13.10.2 Yoga Tree Business Overview and Its Total Revenue

13.10.3 Yoga Tree Complementary and Alternative Medicine Introduction

13.10.4 Yoga Tree Revenue in Complementary and Alternative Medicine Business (2015-2020)

13.10.5 Yoga Tree Recent Development 13.11 The Healing Company

10.11.1 The Healing Company Company Details

10.11.2 The Healing Company Business Overview and Its Total Revenue

10.11.3 The Healing Company Complementary and Alternative Medicine Introduction

10.11.4 The Healing Company Revenue in Complementary and Alternative Medicine Business (2015-2020)

10.11.5 The Healing Company Recent Development 13.12 Quantum Touch

10.12.1 Quantum Touch Company Details

Read more:

Complementary and Alternative Medicine Market Provides An In-Depth Insight Of Sales And Trends, Forecast To 2026 | Columbia Nutritional, Herb Pharm,...

Read the Rest...

What is Quantum Computing, and How does it Help Us? – Analytics Insight

§ October 8th, 2020 § Filed under Quantum Medicine Comments Off on What is Quantum Computing, and How does it Help Us? – Analytics Insight

The term quantum computing gained momentum in the late 20thcentury. These systems aim to utilize these capabilities to become highly-efficient. They use quantum bits or qubits instead of the simple manipulation of ones and zeros in existing binary-based computers. These qubits also have a third state called superposition that simultaneously represents a one or a zero. Instead of analyzing a one or a zero sequentially, superposition allows two qubits in superposition to represent four scenarios at the same time. So we are at the cusp of a computing revolution where future systems have capability beyond mathematical calculations and algorithms.

Quantum computers also follow the principle of entanglement, which Albert Einstein had referred to as spooky action at a distance. Entanglement refers to the observation that the state of particles from the same quantum system cannot be described independently of each other. Even when they are separated by great distances, they are still part of the same system.

Several nations, giant tech firms, universities, and startups are currently exploring quantum computing and its range of potential applications. IBM, Google, Microsoft, Amazon, and other companies are investing heavilyin developing large-scale quantum computing hardware and software. Google and UCSB have a partnership to develop a 50 qubits computer, as it would represent 10,000,000,000,000,000 numbers that would take a modern computer petabyte-scale memory to store. A petabyte is the unit above a terabyte and represents 1,024 terabytes. It is also equivalent to 4,000 digital photos taken every day. Meanwhile, names like Rigetti Computing, D-Wave Systems, 1Qbit Information Technologies, Inc., Quantum Circuits, Inc., QC Ware, Zapata Computing, Inc. are emerging as bigger players in quantum computing.

IEEE Standards Association Quantum Computing Working Group is developing two technical standards for quantum computing. One is for quantum computing definitions and nomenclature, so we can all speak the same language. The other addresses performance metrics and performance benchmarking to measure quantum computers performance against classical computers and, ultimately, each other. If required, new standards will also be added with time.

The rapid growth in the quantum tech sector over the past five years has been exciting. This is because quantum computing presents immense potential. For instance, a quantum system can be useful for scientists for conducting virtual experiments and sifting through vast amounts of data. Quantum algorithms like quantum parallelism can perform a large number of computations simultaneously. In contrast, quantum interference will combine their results into something meaningful and can be measured according to quantum mechanics laws. Even Chinese scientists are looking to developquantum internet, which shall be a more secure communication system in which information is stored and transmitted withadvanced cryptography.

Researchers at Case Western Reserve University used quantum algorithms to transform MRI scans for cancer, allowing the scans to be performed three times faster and to improve their quality by 30%. In practice, this can mean patients wont need to be sedated to stay still for the length of an MRI, and physicians could track the success of chemotherapy at the earliest stages of treatment.

Laboratoire de Photonique Numrique et Nanosciences of France has built a hybrid device that pairs a quantum accelerometer with a classical one and uses a high-pass filter to subtract the classical data from the quantum data. This has the potential to offer an highly precise quantum compass that would eliminate the bias and scale factor drifts commonly associated with gyroscopic components. Meanwhile, the University of Bristolhas founded a quantum solution for increasing security threats. Researchers at the University of Virginia School of Medicine are working to uncover the potential quantum computers hold to help understand genetic diseases.Scientists are also using quantum computing to find a vaccine for COVID and other life-threatening diseases.

In July 2017, in collaboration with commercial photonics tools providerM Squared, QuantIC demonstrated how a quantum gravimeter detects the presence of deeply hidden objects by measuring disturbances in the gravitational field. If such a device becomes practical and portable, the team believes it could become invaluable in an early warning system for predicting seismic events and tsunamis.

See the article here:

What is Quantum Computing, and How does it Help Us? - Analytics Insight

Read the Rest...

Research infrastructure upgrades key project within GO Bond C – UNM Newsroom

§ October 8th, 2020 § Filed under Quantum Medicine Comments Off on Research infrastructure upgrades key project within GO Bond C – UNM Newsroom

Buildings, classrooms, electrical, high-speed internet, optical fiber, research laboratories the importance of education infrastructure cannot be overstated. Studies have shown that high-quality academic and research infrastructure leads to better instruction and research, better student outcomes and increased graduation rates.

During this years general election, voters statewide have the opportunity to help The University of New Mexico upgrade old and outdated technology in many key areas across campus with the passage of GO Bond C, which includes a $2 million research infrastructure upgrade project critical to research and student success. Passage of the GO Bond C will NOT increase taxes and will help generate more than 1,500 jobs across New Mexico.

Part of the funds for the Center for High Tech Materials (CHTM) will be used to address critical facility needs including an upgrade to existing facilities infrastructure, repurpose several laboratories and to acquire high-performance equipment to develop advanced capabilities for a quantum materials and technology laboratory, a field with huge growth potential following the National Quantum Initiative Act signed into law in December 2018. Quantum materials are used in high-speed communications, ultrafast computers, space explorations, defense industries and medicine.

Quantum materials is a way for us to connect our past success to our future growth and to establish CHTM as the place to do materials research in the coming decades, said Arash Mafi, director of the Center for High Technology Materials (CHTM) and physics professor. We understand that weve asked the voters for a lot of support over the years for technology and for research. This additional investment will allow us to attract even more great faculty and provide more opportunities for students that will enhance greatly our mission at The University of New Mexico.

This project was developed due to the critical need for long-neglected facility and infrastructure renewal and improvements, which will renew and upgrade critical campus-wide academic and research infrastructure on UNMs main campus. Research is a fundamental aspect of UNMs mission. As the only Carnegie R1 Flagship Institution in New Mexico, the development and maintenance of high-quality research infrastructure is a priority.

Our charge is to foster a culture of excellence in research and education. This bond is very important to us because it will allow us to continue performing cutting edge research, said Mafi. Over the past 37 years, the CHTM has given back over $400 million to the state economy while the research at CHTM has resulted in over 600 graduate degrees many of those (graduates) are working in the state of New Mexico in the high tech industry.

Other projects included as part of the $2 million research infrastructure project include Castetter Hall to upgrade a cage wash facility to meet laboratory standards and upgrade 40+ year-old cage/bottle washer; a 4,500 square feet of shelled space in Farris Engineering to upgrade UNMs Innovation Plaza with inter/multi/transdisciplinary laboratory space; refurbishment of a Mechanical Engineering Lab to accommodate the operation of a hydrogen furnace and a Biology Lab Renovation to renew HVAC, casework/sinks, upgrade power and lab utilities to best support bioinformatics/genomics research in support of UNMs interdisciplinary Data to Knowledge initiative.

For more information, visit UNM Bonds.

Continued here:

Research infrastructure upgrades key project within GO Bond C - UNM Newsroom

Read the Rest...

Toward Live Imaging with a Lighthouse-like Microlens – Optics & Photonics News

§ October 8th, 2020 § Filed under Quantum Medicine Comments Off on Toward Live Imaging with a Lighthouse-like Microlens – Optics & Photonics News

In this cross-section view of a SRS microscope, a red laser beam is strongly focused by a high-NA objective to interact with live cells. The 3D-printed, catadioptric Fresnel lens on top collimates thebeam, redirecting it upward toward a photodetector. [Image: 2020 KAUST; Andrea Bertoncini]

Label-free, fast chemical imaging available with stimulated Raman scattering (SRS) microscopy has found powerful applications in biology and medicine. But a phenomenon known as cross-phase modulation (XPM) can create background signals that ruin the picture.

Now, a 3D-printed lensreminiscent of the Fresnel lens used in lighthousescould be used to eliminate XPM and expand the capabilities of this important spectroscopic method, reports a research team in Saudi Arabia (J. Biophoton., doi: 10.1002/jbio.202000219).

In SRS microscopy, two laser pulses collect molecular vibrational signals from biological samples. The vibrational signals allow SRS microscopes to map the 3D distribution of chemical bonds within a sample with sufficient speed and sensitivity to allow near-real-time imaging, explains co-author Carlo Liberale, assistant professor of bioscience at King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia.

The XPM effect occurs, he says, when the two intense laser beams used in an SRS microscope setup interact to create a non-resonant signal indistinguishable from the desired Raman signal from the sample. It can be suppressed using high-numerical-aperture (high-NA) microscope objectives to collect the laser beams after their interaction with the sample, but this implies very short working distances.

The thin, affordable lens is 3D printed and has the capacity to put live cells under the microscope. [Image: 2020 KAUST; Andrea Bertoncini]

This limitation became a stumbling block for the researchers. When they started doing live-cell SRS microscopy with an inverted microscope and a stage-top incubator to keep the right conditions for the cells, the incubator was not compatible with the high-NA collection optics.

To reject the XPM background in SRS microscopy, Liberale says, researchers need a way to collect a highly-focused beam over the largest possible anglethat is, the largest NAbut without any special need for imaging quality of the collection optics.

We just needed a non-imaging optical element, Liberale says, which relaxes the requirements for its optical design.

Enter the lighthouse lens idea. In its complete version, such lenses include both refractive [lens-like] and reflective elements, Liberale says. The lens is a catadioptric element. Indeed, lighthouse Fresnel lenses used a catadioptric design to redirect the light of a torch towards distant ships, to signal the presence of land.

Its a very efficient way to collect and redirect light from a source that emits rays over a very wide anglein this case, the torch, says co-author Andrea Bertoncini, a member of Liberales group. In our case, this wide angle is with the laser beam to be collected,which emerges highly divergent after having been tightly focused on the sample.

The next challenge for the KAUST team was fitting the 3D-printed microlens to the microscope setup.

Initially, we struggled to find a mounting strategy that would guarantee a precise working distance, and that could fit the lens inside the incubator, Liberale says. The solution was hiding in plain sight: We redesigned the lens to have a working distance matching the depth of the petri dish well.

This solution of how to incorporate the lens, he says, stems from the fact that, beyond developing tools, we directly work with applicationsin this case live-cell microscopyand so we have ended up with an arrangement which reusesthe petri dish also as part of the optical configuration.

The teams lens was printed with a technology based on two-photon lithography, first presented about 20 years ago. According to Liberale, the technique allows 3D printing with a spatial resolution better than popular consumer or professional 3D printers. Recent advances have provided new printable materials and printing configurations suited to fabricating micro-optics, he adds.To further enhance the collection capability of the teams lens, Bertoncini says, an antireflective coating could be added to the surface of its 3D micro-elements.

Our lens is thin, reusable and easily integrated just by laying it on top of the sample, Bertoncini says, and it could be incorporated into commercial laboratory equipment for SRS microscopy or other applications.

Imaging techniques employing highly-focused and thus highly divergent beams could indeed benefit from the high-NA collection capability of our lens, Liberale says. We think it could find applications not only in bioimaging but also in material science, for example, the collection of photons from quantum emitters.

For their study, the researchers imaged liver cancer cells, but Liberale says SRS microscopy is a powerful bioimaging tool for a variety of biomedical studies. We expect the range of applications to expand, says Liberale. We believe that the improvement in SRS microscopy provided by our lens could benefit all experiments for which its crucial to image live-cells under precise environmental conditions.

Originally posted here:

Toward Live Imaging with a Lighthouse-like Microlens - Optics & Photonics News

Read the Rest...

Texas A&M’s Roderic Pettigrew Announced As Vannevar Bush Award Winner – Texas A&M University Today

§ September 28th, 2020 § Filed under Quantum Medicine Comments Off on Texas A&M’s Roderic Pettigrew Announced As Vannevar Bush Award Winner – Texas A&M University Today

Dr. Roderic Pettigrew, CEO of Engineering Health and executive dean for Engineering Medicine (EnMed) at Texas A&M University.

Texas A&M Division of Marketing & Communications

Texas A&Ms chief executive officer over the Engineering Health program and executive dean for Engineering Medicine will receive prestigious lifetime achievement award from the National Science Board.

The organization announced Monday that RodericPettigrewwill be presented with theVannevar Bush Award, which is considered one of the nations highest science awards. It honors lifelong science and technology leaders who have made exceptional contributions to the welfare of the nation through public service in science and technology and in shaping public policy.

RodericPettigrews passion and creativity have spurred innovation in biomedicine, saidVictor McCrary, vice chair of the National Science Board and chair of the 2020 NSB Honorary Awards Subcommittee. His reimagining of healthcare solutions is helping converge science fields, narrowing gaps between disciplines in a way that really impacts society.Pettigrewis helping us to see what might be, what could be, and what is possible.

Pettigrews contributions are wide-ranging. They include:

Pettigrews work also involved bringing out the best in others. While at NIH created the Quantum Grants Program to encourage researchers to undertake medical moon shots to solve major challenges through technological innovation.

Pettigrew continues to help others archive greatness at Texas A&M, where he helped found EnMed in Houston. The program blends engineering and medicine in a 4-year curriculum to develop problem-solving physicianeers; graduates who earn a medical degree and a masters degree in engineering. Plus, they must invent a solution to a healthcare problem that is ready for a patent.

It is an incredible honor to receive the Vannevar Bush Award, which is so steeped in science history,Pettigrewsaid. My only regret is that my parents are not alive to share this honor. They were my first role models.

Texas A&M President Michael K. Youngs pride in Pettigrew is shown in a letter he sent to campus earlier today.

All of us at Texas A&M have long been impressed not only by Dr. Pettigrews extraordinary breadth and depth of personal knowledge, but also his understanding that the greatest breakthroughs come from building bridges across many different disciplines, Young wrote in the letter. Through his exceptional leadership of our EnMed program and his work to shape public policy, his visionary ideas and his collaborative efforts have helped him have a profound influence on numerous innovations that have solved pressing problems and saved lives.

Pettigrewwas raised in rural Georgia and attended segregated public schools before attending Morehouse College in Atlanta through a Merrill Scholarship. After graduating with a B.S. in physics in 1972, he earned a M.S. in nuclear science and engineering at Rensselaer Polytechnic Institute and a Ph.D. in Applied Radiation Physics at Massachusetts Institute of Technology, where his work resulted in a new type of neutron activation radiation treatment of malignant brain tumors being pioneered at MIT-Harvard. In 1979 he received an M.D. from the University of Miami.

In recent years, he has been elected to the National Academy of Medicine, the National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Sciences India. He has received the Pierre Galletti Award from the American Institute for Medical and Biological Engineering, the Distinguished Service Award of both the International Society of Magnetic Resonance in Medicine and National Medical Association, the Pritzker Achievement Award of the Biomedical Engineering Society, and was the first winner of the Gold Medal of the Academy of Radiology Research. He also was awarded a Gold Medal from the Radiological Society of North America and received the Arthur M. Bueche Award from the National Academy of Engineering

The NSB created the award in 1980 in memory of Vannevar Bush, who served as a science advisor to President Franklin Roosevelt during World War II, helped to establish federal funding for science and engineering as a national priority during peacetime and was behind the creation of the National Science Foundation.Past award recipients include: Leon Lederman (Fermilab), Nobel Laureate Harold Varmus (former NIH Director), Nobel Laureate Charles Townes (UC Berkeley -Laser Inventor), David Packard (Hewlett-Packard Company), Rita Colwell (former NSF Director), Charles Vest (former MIT President), and last year, Walter Massey (University of Chicago oversaw Giant Magellan Telescope).

Continued here:

Texas A&M's Roderic Pettigrew Announced As Vannevar Bush Award Winner - Texas A&M University Today

Read the Rest...

NVIDIA : Drug Discovery in the Age of COVID-19 – Marketscreener.com

§ September 28th, 2020 § Filed under Quantum Medicine Comments Off on NVIDIA : Drug Discovery in the Age of COVID-19 – Marketscreener.com

Drug discovery is like searching for the right jigsaw tile - in a puzzle box with 1060 molecular-size pieces. AI and HPC tools help researchers more quickly narrow down the options, like picking out a subset of correctly shaped and colored puzzle pieces to experiment with.

An effective small-molecule drug will bind to a target enzyme, receptor or other critical protein along the disease pathway. Like the perfect puzzle piece, a successful drug will be the ideal fit, possessing the right shape, flexibility and interaction energy to attach to its target.

But it's not enough just to interact strongly with the target. An effective therapeutic must modify the function of the protein in just the right way, and also possess favorable absorption, distribution, metabolism, excretion and toxicity properties - creating a complex optimization problem for scientists.

Researchers worldwide are racing to find effective vaccine and drug candidates to inhibit infection with and replication of SARS-CoV-2, the virus that causes COVID-19. Using NVIDIA GPUs, they're accelerating this lengthy discovery process - whether for structure-based drug design, molecular docking, generative AI models, virtual screening or high-throughput screening.

To develop an effective drug, researchers have to know where to start. A disease pathway - a chain of signals between molecules that trigger different cell functions - may involve thousands of interacting proteins. Genomic analyses can provide invaluable insights for researchers, helping them identify promising proteins to target with a specific drug.

With the NVIDIA Clara Parabricks genome analysis toolkit, researchers can sequence and analyze genomes up to 50x faster. Given the unprecedented spread of the COVID pandemic, getting results in hours versus days can have an extraordinary impact on understanding the virus and developing treatments.

To date, hundreds of institutions, including hospitals, universities and supercomputing centers, in 88 countries have downloaded the software to accelerate their work - to sequence the viral genome itself, as well as to sequence the DNA of COVID patients and investigate why some are more severely affected by the virus than others.

Another method, cryo-EM, uses electron microscopes to directly observe flash-frozen proteins - and can harness GPUs to shorten processing time for the complex, massive datasets involved.

Using CryoSPARC, a GPU-accelerated software built by Toronto startup Structura Biotechnology, researchers at the National Institutes of Health and the University of Texas at Austin created the first 3D, atomic-scale map of the coronavirus, providing a detailed view into the virus' spike proteins, a key target for vaccines, therapeutic antibodies and diagnostics.

Once a target protein has been identified, researchers search for candidate compounds that have the right properties to bind with it. To evaluate how effective drug candidates will be, researchers can screen drug candidates virtually, as well as in real-world labs.

New York-based Schrdinger creates drug discovery software that can model the properties of potential drug molecules. Used by the world's biggest biopharma companies, the Schrdinger platform allows its users to determine the binding affinity of a candidate molecule on NVIDIA Tensor Core GPUs in under an hour and with just a few dollars of compute cost - instead of many days and thousands of dollars using traditional methods.

Rather than evaluating a dataset of known drug candidates, a generative AI model starts from scratch. Tokyo-based startup Elix, Inc., a member of the NVIDIA Inception virtual accelerator program, uses generative models trained on NVIDIA DGX Station systems to come up with promising molecular structures. Some of the AI's proposed molecules may be unstable or difficult to synthesize, so additional neural networks are used to determine the feasibility for these candidates to be tested in the lab.

With DGX Station, Elix achieves up to a 6x speedup on training the generative models, which would otherwise take a week or more to converge, or to reach the lowest possible error rate.

With the inconceivable size of the chemical space, researchers couldn't possibly test every possible molecule to figure out which will be effective to combat a specific disease. But based on what's known about the target protein, GPU-accelerated molecular dynamics applications can be used to approximate molecular behavior and simulate target proteins at the atomic level.

Software like AutoDock-GPU, developed by the Center for Computational Structural Biology at the Scripps Research Institute, enables researchers to calculate the interaction energy between a candidate molecule and the protein target. Known as molecular docking, this computationally complex process simulates millions of different configurations to find the most favorable arrangement of each molecule for binding. Using the more than 27,000 NVIDIA GPUs on Oak Ridge National Laboratory's Summit supercomputer, scientists were able to screen 1 billion drug candidates for COVID-19 in just 12 hours. Even using a single NVIDIA GPU provides more than 230x speedup over using a single CPU.

In Illinois, Argonne National Laboratory is accelerating COVID-19 research using an NVIDIA A100 GPU-powered system based on the DGX SuperPOD reference architecture. Argonne researchers are combining AI and advanced molecular modelling methods to perform accelerated simulations of the viral proteins, and to screen billions of potential drug candidates, determining the most promising molecules to pursue for clinical trials.

The drug discovery process involves significant high-throughput lab experiments as well. Phenotypic screening is one method of testing, in which a diseased cell is exposed to a candidate drug. With microscopes, researchers can observe and record subtle changes in the cell to determine if it starts to more closely resemble a healthy cell. Using AI to automate the process, thousands of possible drugs can be screened.

Digital biology company Recursion, based in Salt Lake City, uses AI and NVIDIA GPUs to observe these subtle changes in cell images, analyzing terabytes of data each week. The company has released an open-source COVID dataset, sharing human cellular morphological data with researchers working to create therapies for the virus.

As AI and accelerated computing continue to accelerate genomics and drug discovery pipelines, precision medicine - personalizing individual patients' treatment plans based on insights about their genome and their phenotype - will become more attainable.

Increasingly powerful NLP models will be applied to organize and understand massive datasets of scientific literature, helping connect the dots between independent investigations. Generative models will learn the fundamental equations of quantum mechanics and be able to suggest the optimal molecular therapy for a given target.

To learn more about how NVIDIA GPUs are being used to accelerate drug discovery, check out talks by Schrdinger, Oak Ridge National Laboratory and Atomwise at the GPU Technology Conference next week.

For more on how AI and GPUs are advancing COVID research, read our blog stories and visit the COVID-19 research hub.

Subscribe to NVIDIA healthcare news here.

Disclaimer

Nvidia Corporation published this content on 28 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 September 2020 21:59:07 UTC

Read more:

NVIDIA : Drug Discovery in the Age of COVID-19 - Marketscreener.com

Read the Rest...

Complementary and Alternative Medicine Market report reviews drivers, analysis, share, growth, trends & forecast to 2026 – The Market Records

§ September 28th, 2020 § Filed under Quantum Medicine Comments Off on Complementary and Alternative Medicine Market report reviews drivers, analysis, share, growth, trends & forecast to 2026 – The Market Records

Report Ocean recently published Complementary and Alternative Medicine Market report which highlights the important factors that are expected to shape the growth of the Complementary and Alternative Medicine Market over the forecast period. The current trends, market drivers, opportunities, and restraints are thoroughly evaluated to provide a clear understanding of the current market landscape of the Complementary and Alternative Medicine Market. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porters Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Complementary and Alternative Medicine Market.

The COVID-19 (Coronavirus) outbreak has led to both advantages and disadvantages for companies in the Complementary and Alternative Medicine Market. With the help of our recently published report, market players can adopt innovative strategies to overcome the challenges that lie ahead of the COVID-19 lockdown period. Through our research study, companies can gain factual information about COVID-19 and how its impacting the sales of products in the global market landscape.

Request Free Sample Report athttps://reportocean.com/industry-verticals/sample-request?report_id=mai50485

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain in the Complementary and Alternative Medicine Market. The report Complementary and Alternative Medicine Market provide in-depth analysis of current market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on Complementary and Alternative Medicine Market segments and geographies.

This Complementary and Alternative Medicine Market report begins with a basic overview of the market. The analysis highlights the opportunity and Complementary and Alternative Medicine Market trends that are impacted the market. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Complementary and Alternative Medicine Market insight regarding the things which are driving and affecting the earnings of the market.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Market Data Breakdown by Key Geography, Type & Application / End-User

By type (past and forecast)

Complementary and Alternative Medicine Market: Specific Applications Sales and Growth Rates (Historical & Forecast)

Complementary and Alternative Medicine Market revenue and growth rate by the market (history and forecast)

Complementary and Alternative Medicine Market size and growth rate, application and type (past and forecast)

Competitive Landscape: Key players in the global Complementary and Alternative Medicine market covered in Chapter 4: Herbal Hills Iyengar Yoga Institute Columbia Nutritional Nordic Naturals Helio USA Yoga Tree Pure Encapsulations, Inc Quantum Touch The Healing Company John Schumachers Unity Woods Yoga Center Herb Pharm Deepure Plus Complementary and Alternative Medicine Market competitive landscape provides details and data information by major players. Details included are company description, major business, company total revenue and the sales, revenue generated in Complementary and Alternative Medicine Market business, the date to enter into the Complementary and Alternative Medicine Market, product introduction, recent developments, etc.

Market Segmentation:

The segmentation is used to decide the target market into smaller sections or segments like product type, application, and geographical regions to optimize marketing strategies, advertising technique and global as well as regional sales efforts of Complementary and Alternative Medicine Market.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India, Middle East and Africa and Central and South America.

Study objectives of Complementary and Alternative Medicine Market Report:

To provide economic factors, technology trends, and market trends that influence the global Complementary and Alternative Medicine Market growth

To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries

To provide historical, current, and forecast revenue of market segments based on material, type, design, and end-user

To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global Complementary and Alternative Medicine Market

To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market

Inquire or Share Your Questions If Any before Purchasing This Report:https://reportocean.com/industry-verticals/sample-request?report_id=mai50485

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, and Asia.

Contact Us: +1 888 212 3539 (US) +91-9997112116 (Outside US) Contact Person: Matthew S Email:[emailprotected]

x

View post:

Complementary and Alternative Medicine Market report reviews drivers, analysis, share, growth, trends & forecast to 2026 - The Market Records

Read the Rest...

Alternative Medicines and Therapies Market Growth, Trends and Opportunity 2020-2026 || Major Giants Bio Veda Action Research Co, Tansukh Herbals,…

§ September 28th, 2020 § Filed under Quantum Medicine Comments Off on Alternative Medicines and Therapies Market Growth, Trends and Opportunity 2020-2026 || Major Giants Bio Veda Action Research Co, Tansukh Herbals,…

Alternative Medicines and Therapies Market

A transparent research method has been accomplished with the right tools and techniques to make this Alternative Medicines and Therapies Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porters Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint ventures, partnerships & recent acquisitions. Alternative Medicines and Therapies Market research report adoption plays an essential role for the business growth as it supports with the better decision making, enhancing revenue generation, prioritizing market goals and results in profitable business.

Request for Sample Copy or PDF Herehttps://www.databridgemarketresearch.com/request-a-sample?dbmr=global-alternative-medicines-and-therapies-market

Global alternative medicines and therapies market is market to grow with a substantial CAGR in the forecast period of 2019-2026. Growing prevalence of disease worldwide and advancement in alternatives therapies to prevent of cancer related disorders are the key factors for lucrative growth of market.

Few of the major competitors currently working in the globalalternative medicines and therapies marketareWeleda UK., Wrights Dental, Green Health, Syndy Pharma, Jiva Ayurveda, Bio Veda Action Research Co, Tansukh Herbals, Quantum-Touch, The Healing Company Ltd, Columbia Nutritional, Herb Pharm, Helio USA Inc, Nordic Naturals, Nestle SA, Pure Encapsulations, LLC, ALCES LLPamong others.

Browse Detailed TOC Herehttps://www.databridgemarketresearch.com/toc?dbmr=global-alternative-medicines-and-therapies-market

Report Highlights:

Market Definition: Global Alternative Medicines and Therapies Market

Alternatives medicines and therapiesare referring to the natural practice of the treatment that is used instead of standard medically approved treatment. These medicines can improve the quality of life and help to cope with symptoms caused by diseases. However, lack of scientific proof can give patients false hope but some medicines sound promising for the treatment of various disorders.

Segmentation:Global Alternative Medicines and Therapies Market

Alternative Medicines and Therapies Market : By Intervention Type

Alternative Medicines and Therapies Market : By Disease Type

Alternative Medicines and Therapies Market : By Therapy Type

Alternative Medicines and Therapies Market : By Dosage Form

Alternative Medicines and Therapies Market : By Route of Administration

Alternative Medicines and Therapies Market : By End Users

Alternative Medicines and Therapies Market : ByGeography

Alternative Medicines and Therapies Market Drivers

Key Developments in the Alternative Medicines and Therapies Market:

In July 2019, Nestle SA has reported in their press release that their clinical, randomized controlled trial of food diet with Modulen demonstrated that 80% of patients with Crohns disease achieved promising results. If clinical trial successful, it will be highly effective treatment with absolutely no side effects will be accessible to all the patients with Crohns disease

In July 2018, Pure Encapsulations, LLC, revealed that Neurophenol which is a polyphenol-rich extract of blueberry and grape can prevent age-related memory decline. This finding will hold potential promise for the treatment of patients with mild cognitive impairments

Alternative Medicines and Therapies Market Restraints

Opportunities in the Alternative Medicines and Therapies Market Report :

Want Full Report? Enquire Here @https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-alternative-medicines-and-therapies-market

About Data Bridge Market Research:

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail:[emailprotected]

Follow this link:

Alternative Medicines and Therapies Market Growth, Trends and Opportunity 2020-2026 || Major Giants Bio Veda Action Research Co, Tansukh Herbals,...

Read the Rest...

Preventive Medicine: Why the COVID math might be wrong – CT Insider

§ September 26th, 2020 § Filed under Quantum Medicine Comments Off on Preventive Medicine: Why the COVID math might be wrong – CT Insider

How many cases of COVID have occurred in the United States to date ? As I write this, the official tally is approximately 6.5 million, and this is not just wrong, but absurdly wrong.

By way of reminder, epidemics are like icebergs: the visible manifestations are just the tip. In the case of COVID, hospitalizations and deaths are readily visible; mild and asymptomatic cases are hidden from view absent the methodical testing we have failed to practice from the start.

A recent publication, aligned with many others before it, indicates that actual case counts in the U.S. are fully an order of magnitude higher than weve documented. That would mean not 6.5 million cases, but 65 million cases, or one of every 5 Americans.

Facts issue from valid mathematical operations if but only if the correct numbers are plugged into them. The 10-fold figure is probably right, but it would be good to verify it. Mathematical estimations become quite a bit more convincing when entirely independent models lead to the same outcome. In this case, they do.

Multiple sources most recently the New England Journal of Medicine, reporting data out of Iceland indicate that the infection fatality rate (IFR) for COVID is approximately 0.3 percent, or less. What would it mean for the roughly 200,000 COVID-attributed deaths in the United States (to date) to conform to this consistent, global pattern?

The algebraic equation for that is: [(0.3%) * X = 200,000]. The solution for X is 67 million. This is, but for rounding, just the same as the 10X number above. These two, fully independent methods, both indicate that the United States is misgauging case counts by an order of magnitude. This is non-partisan, ideology-free math; it is very probably the truth.

UnlessCOVID is just 10 times more lethal to Americans than anyone else around the world. There is a scant quantum of plausibility there, because our culture not only condones, but actively propagates for profit, an outrageous burden of heart disease, hypertension, obesity, and diabetes that shift the COVID mortality risks of the young toward those of the elderly. But such effects fall massively below a ten-fold increase in COVID mortality. There are large burdens of these conditions in Europe, too, so this is not the explanation.

So, yes, Americans are dying unnecessarily where our long-neglected chronic disease epidemic overlaps with COVID, but incrementally more of us, not 10 times more of us. The primary explanation iswe have failed to populate the denominator accurately. The mathematical implications of doing so now are that we have had at least 65 million cases here.

Or perhaps, many more. Studies have consistently revealed that much of the immunity achieved after COVID infection, particularly after mild or asymptomatic infection, is not reflected in the production of the IgG antibodies we capture in seroprevalence research. Much of the immunity is expressed in memory T cells and IgA, and these we do not measure. In other words, the seroprevalence studies are under-representing case counts, too.

By how much? In the recent New England Journal of Medicine paper, among even those recovered from symptomatic infection, 10 percent did not produce measurable IgG. The apparent majority of COVID cases are minimally symptomatic or asymptomatic. Data suggest that asymptomatic bouts of COVID may fail to produce IgG or result in only fleeting levels.

In addition, we have long had evidence, increasing over the span of the pandemic, that many of us who get exposed to SARS-CoV-2 simply do not get infected with it. The reason is apparently native resistance, resulting from prior exposure to related germs, namely common cold coronaviruses.

Published data on this topic suggest that 40 percent of us, and up to 90 percent of us, may have prior, native resistance of one degree or another to the COVID-19 pathogen.

Put reasonable numbers into valid mathematical formulas, and the results are reliably free of drama, dogma, distortion or hype. The results are non-partisan, and directed toward neither comfort, nor affliction. They incline simply, dispassionately towardtruth. What we do with it is up to us.

Dr. David L. Katz is a board-certified specialist in Preventive Medicine/Public Health.

Read more:

Preventive Medicine: Why the COVID math might be wrong - CT Insider

Read the Rest...

Appointments, honors and activities – Purdue News Service

§ September 26th, 2020 § Filed under Quantum Medicine Comments Off on Appointments, honors and activities – Purdue News Service

Angelica Duran, professor of English, comparative literature and religious studies, has published a book on John Milton and has been selected as president of the John Milton Society of America. Durans sixth book, Milton Among Spaniards (University of Delaware Press, 2020) was published in April. The Milton Society of America is an affiliate organization of the Modern Language Association and the Renaissance Society of America.

Shaimaa I. Azzam, who earned her doctoral degree in nanophotonics over the summer from the School of Electrical and Computer Engineering, has been awarded a 2020 Dimitris N. Chorafas Foundation award. Azzams submission was titled Novel Light Trapping and Nonlinear Dynamics in Nanophotonic Devices. Now at the University of California, Santa Barbara, she is an Elings Prize Postdoctoral Fellow working in the area of quantum photonics. The Dimitris N. Chorafas Foundation, part of the Feinberg Graduate School at Weizmann Institute of Science, awards scientific prizes for outstanding work in selected fields in the engineering sciences, medicine and the natural sciences.More information available.

QS World University Rankings has placed three masters degree programs offered by Purdue's Krannert School of Management among the top globally. The school's master's program in Global Supply Chain Management made its debut in the annual rankings at No. 8, while its masters programs in Business Analytics and Information Management and Marketing rank globally at No. 13 and No. 26, respectively. The 2021 rankings, which include surveys of academics and employers, are based on four components: academic reputation, employer reputation, research citations per paper and h-index, which measures productivity and impact of published works.

See original here:

Appointments, honors and activities - Purdue News Service

Read the Rest...

The New SQUID: A Tiny Instrument to Measure the Faintest Magnetic Fields – SciTechDaily

§ September 26th, 2020 § Filed under Quantum Medicine Comments Off on The New SQUID: A Tiny Instrument to Measure the Faintest Magnetic Fields – SciTechDaily

David Indolese, a Physicist at the University of Basel, shortly explains the new SQUID a minuscule instrument able to detect extremely faint magnetic fields. At the heart of the superconducting quantum interference device are two atomically thin layers of graphene, which the researchers combined with boron nitride. Credit: Swiss Nanoscience Institute, University of Basel

Physicists at the University of Basel have developed a minuscule instrument able to detect extremely faint magnetic fields. At the heart of the superconducting quantum interference device are two atomically thin layers of graphene, which the researchers combined with boron nitride. Instruments like this one have applications in areas such as medicine, besides being used to research new materials.

To measure very small magnetic fields, researchers often use superconducting quantum interference devices, or SQUIDs. In medicine, their uses include monitoring brain or heart activity, for example, while in the earth sciences researchers use SQUIDs to characterize the composition of rocks or detect groundwater flows. The devices also have a broad range of uses in other applied fields and basic research.

The team led by Professor Christian Schnenberger of the University of Basels Department of Physics and the Swiss Nanoscience Institute has now succeeded in creating one of the smallest SQUIDs ever built. The researchers described their achievement in the scientific journal Nano Letters.

A conventional superconducting quantum interference device (SQUID) consists of a superconducting ring interrupted at two points by weak links (in this case a graphene layer.) Credit: University of Basel, Department of Physics

To measure very small magnetic fields, researchers often use superconducting quantum interference devices, or SQUIDs. In medicine, their uses include monitoring brain or heart activity, for example, while in the earth sciences researchers use SQUIDs to characterize the composition of rocks or detect groundwater flows. The devices also have a broad range of uses in other applied fields and basic research.

The team led by Professor Christian Schnenberger of the University of Basels Department of Physics and the Swiss Nanoscience Institute has now succeeded in creating one of the smallest SQUIDs ever built. The researchers described their achievement in the scientific journal Nano Letters.

A typical SQUID consists of a superconducting ring interrupted at two points by an extremely thin film with normal conducting or insulating properties. These points, known as weak links, must be so thin that the electron pairs responsible for superconductivity are able to tunnel through them. Researchers recently also began using nanomaterials such as nanotubes, nanowires or graphene to fashion the weak links connecting the two superconductors.

The new SQUID is made up of a stack of two-dimensional materials, including two graphene layers separated by a thin film of boron nitride. Credit: University of Basel, Department of Physics

As a result of their configuration, SQUIDs have a critical current threshold above which the resistance-free superconductor becomes a conductor with ordinary resistance. This critical threshold is determined by the magnetic flux passing through the ring. By measuring this critical current precisely, the researchers can draw conclusions about the strength of the magnetic field.

Our novel SQUID consists of a complex, six-layer stack of individual two-dimensional materials, explains lead author David Indolese. Inside it are two graphene monolayers separated by a very thin layer of insulating boron nitride. If two superconducting contacts are connected to this sandwich, it behaves like a SQUID meaning it can be used to detect extremely weak magnetic fields.

In this setup, the graphene layers are the weak links, although in contrast to a regular SQUID they are not positioned next to each other, but one on top of the other, aligned horizontally. As a result, our SQUID has a very small surface area, limited only by the constraints of nanofabrication technology, explains Dr. Paritosh Karnatak from Schnenbergers team.

The tiny device for measuring magnetic fields is only around 10 nanometers high roughly a thousandth of the thickness of a human hair. The instrument can trigger supercurrents that flow in minuscule spaces. Moreover, its sensitivity can be adjusted by changing the distance between the graphene layers. With the help of electrical fields, the researchers are also able to increase the signal strength, further enhancing the measurement accuracy.

The Basel research teams primary goal in developing the novel SQUIDs was to analyze the edge currents of topological insulators. Topological insulators are currently a focus of countless research groups all over the world. On the inside, they behave like insulators, while on the outside or along the edges they conduct current almost losslessly, making them possible candidates for a broad range of applications in the field of electronics.

With the new SQUID, we can determine whether these lossless supercurrents are due to a materials topological properties, and thereby tell them apart from non-topological materials. This is very important for the study of topological insulators, remarked Schnenberger of the project. In future, SQUIDs could also be used as low-noise amplifiers for high-frequency electrical signals, or for instance to detect local brainwaves (magnetoencephalography), as their compact design means a large number of the devices can be connected in series.

Reference: Compact SQUID Realized in a Double-Layer Graphene Heterostructure by David I. Indolese, Paritosh Karnatak, Artem Kononov, Raphalle Delagrange, Roy Haller, Lujun Wang, Pter Makk, Kenji Watanabe, Takashi Taniguchi and Christian Schnenberger, 1 September 2020, Nano Letters. DOI: 10.1021/acs.nanolett.0c02412

The paper is the outcome of close collaboration among groups at the University of Basel, the University of Budapest and the National Institute for Material Science in Tsukuba (Japan).

Continued here:

The New SQUID: A Tiny Instrument to Measure the Faintest Magnetic Fields - SciTechDaily

Read the Rest...

Alice Lowe’s teen obsessions: ‘Under the bed was Keanu Reeves folded into tiny pieces’ – The Guardian

§ September 24th, 2020 § Filed under Quantum Medicine Comments Off on Alice Lowe’s teen obsessions: ‘Under the bed was Keanu Reeves folded into tiny pieces’ – The Guardian

Alice Rowe (right) and Charlotte Coleman in Four Weddings and a Funeral; Keanu Reeves and Gary Oldman in Bram Stokers Dracula; and The X-Files. Illustration: Guardian Design; photographs: Linda Nylind/The Guardian; Sportsphoto/Allstar; BBC Two

I never gave my parents enough credit for their great taste in TV. We would all sit down and watch Dennis Potter and Twin Peaks together and my mum really encouraged me and my sister to see Oranges Are Not the Only Fruit perhaps trying to give us an opportunity to tell her something. Then we both disappointed her by being straight. She had this romantic fantasy of herself as a mother who would be completely the opposite to the one in the show.

I hate the word quirky but you just didnt see that many female characters who were allowed to have a personality back then. I had loved Charlotte Colemans punk aesthetic in Marmalade Atkins and later in Four Weddings and a Funeral. Many years later I did a read-through with her and said, My mum is a massive fan of yours. And, because I had just been in Garth Marenghi, which had won the Perrier, she said, Your mum must be so proud of you. She was so sweet. She died about two weeks later and it was a real, real shock. She was lovely.

I really had a thing about Jesus. I built a shrine to him in a medicine cabinet in my bedroom, not because I was religious but because I fancied him. I thought you could be into him in the way that you could be into A-ha. I just thought he was gorgeous.

Ive always liked bearded men. My friend and I would watch a VHS of John Boormans Excalibur over and over. It wasnt fashionable to be bearded until The Lord of the Rings and then onwards, thank God. Otherwise, I wouldnt have a partner now. But back then very few people had beards except Merlin and Jesus.

I loved The X-Files and Quantum Leap. Shows that were kind of supernatural felt huge to my teenage self, as if something was coming actually it was just probably my future. Portishead felt connected to that, too: spooky and unknown. You dont tend to connect gothic with the 90s, but there was plenty of that stuff to be found and believe me, I found it. I was too young to be a proper goth, so instead I had to visit castles and watch Bram Stokers Dracula. I was really into pre-Raphaelite stuff and put postcards round my room of John William Waterhouse paintings of The Lady of Shalott and Ophelia, which is probably why my mum thought I was a lesbian.

I was so in love with him, but I kept it a secret. I thought it was embarrassing to put up a poster of him or [A-has] Morten Harket. But under the bed would be Keanu Reeves folded into tiny pieces.

My sister is a brilliant writer and she won a competition where the prize was a years subscription to Sight & Sound. I would read it cover to cover in case there was a tiny scrap of information about Reeves buried in one of the essays. So I credit him with all my film knowledge. My General Studies A-level essay was about VFX in Jurassic Park versus practical effects in Dracula. I argued that analogue effects were more uncanny than CGI and I stand by that. I still love Dracula, though I think it loses its way as soon as Anthony Hopkins comes in.

Vic and Bobs Big Night Out blew my mind, and I loved Morwenna Bankss Absolutely, but I would watch all sitcoms. So I would sit down and watch Desmonds and Cheers and Golden Girls and the Brittas Empire and Red Dwarf. Chris Barrie was clean-cut and good looking but I fancied Danny John-Jules. He was just cool. What with the clothes and dandyish aspect, he was sort of the honorary Prince of Red Dwarf. He was also the funniest. I went to see The Mary Whitehouse Experience live. It was like the Beatles; you had to choose one to fancy and of course it was Rob Newman.

They were these otherworldly creatures who were a validation if you were a slightly dorky girl who was into doing weird drawings. They were chameleonic and mercurial and their being women and taking authorship of that kind of transformation was amazing. Now there are a billion singers with weird hair who dress like sea creatures, but back then Bjrk felt unique.

A lot of comedians yearn to be musicians; think of Ricky Gervais and Bowie. I did an Edinburgh show based on Kate Bush because I just loved her and wanted to be her. Sometimes, I feel like theres this agonising one degree of separation between us and then Im like, God, Im just thinking like a stalker. We have a picture of Kate Bush on the wall and once a babysitter came round and mentioned he was in her Hammersmith show. She sometimes talks about doing soundtracks for films and I would obviously die if she did one for my film.

Jethro Tull. Fleetwood Mac. Weird proggy stuff I found in my mum and dads record collection or in the charity shop. In the 90s, if you liked folk it was really just Clannad, unless you dug into the 70s to find things you thought magical. Cat Stevens looked like Jesus, so I would listen to him on a loop and cry and be lonely and draw pictures of Medusa.

I never had the money to buy records. So it was always a bit passed-on; secondhand fandom. You had to tape-record the charts. You would go to Woolworths and contemplate for weeks whether to buy an album.

I did go to see Blur and Oasis, but because it was sort of the law; my best friends said, Youll regret not going. I was a bit more of a Pulp girl, but Britpop wasnt quite my time. I was talking to someone recently and they were like, God, I loved the 90s. But I didnt. I had terrible skin and a terrible diet. Most of the time I would sit in my bedroom, listening to vinyl, depressed and eating a vegetable pizza.

See the original post:

Alice Lowe's teen obsessions: 'Under the bed was Keanu Reeves folded into tiny pieces' - The Guardian

Read the Rest...

Viral shedding low after 10 days of Covid symptoms onset – The Indian Express

§ September 24th, 2020 § Filed under Quantum Medicine Comments Off on Viral shedding low after 10 days of Covid symptoms onset – The Indian Express

Written by Parul | Chandigarh | September 24, 2020 10:52:53 am According to the findings of the WHO, patients whose symptoms have resolved, may still test positive for COVID-19 virus for several weeks. (Representational)

A senior doctors patient retested COVID positive after 17 days of quarantine after he made a choice to test again for the safety of his family and the community. He tested positive for the second time, and was asked by the authorities to quarantine again for 17 days, which prompted the doctor to address a letter this week to the Deputy Medical Superintendent, GMSH, Sector 16, to clarify the stance of the government on quarantine of COVID positive patients who test positive after 17 days, and direct doctors on the way forward on this issue.

The government recommends no test after 17 days of quarantine. If people go out after 17 to 18 days without being tested again, many of them will be positive, albeit would be shedding low quantum of virus. This person was extra cautious to get it done by choice, but does not need to be re-quarantined and probably needs to be isolated for five more days. Shedding of viral particles will be negligible after 15 days, so the chance of contagion is very low. Also, viral shedding is more in symptomatic patients, through sneezing, coughing, talking, breathing and less in asymptomatic patients. So, all that we are asking is their stance on this issue, the doctor says.

The WHO, on May 27, 2020, published an updated guidance on the clinical management of COVID-19, presenting recommendations on the criteria for discharging patients from quarantine or isolation. According to the findings, which the organisation reflected upon was that patients whose symptoms have resolved, may still test positive for COVID-19 virus for several weeks. In spite of this positive test, the patients are not likely to be infectious and are unlikely to be able to transmit the virus to someone.

Viral shedding, explains Dr Vikas Bhutani, Director Internal Medicine, Fortis Hospital, is when a virus replicates inside the hosts body and is released into the environment and at that point, it may be contagious. After the onset of illness, the detectable viral burden usually declines over a period of time and reaches low/negligible levels at day 10. For most patients with COVID-19, efforts to isolate live virus from upper respiratory tract specimens across the globe have been unsuccessful when specimens are collected more than 10 days after illness onset. Recovery of live virus between 10 and 20 days after symptom onset has been documented in some persons with severe COVID-19, especially immuno-compromised.

As per the data and experience with other viral respiratory infections indicate that most persons recovered from COVID-19 who test persistently or recurrently positive by RT-PCR are likely no longer infectious. As per CDC, USA, isolation and precautions may be discontinued for persons with COVID-19, 10 days after symptom onset, the date on which symptoms first began, including non-respiratory symptoms, provided their fever has resolved for at least 24 hours, without the use of fever-reducing medications, and their other symptoms have improved. For some persons with severe disease and immuno-compromised state, precautions have to be maintained for up to 20 days after symptom onset. So, no, repeat quarantine is not required, as these patients are not likely to be infectious.

For persons who remain asymptomatic following recovery from COVID-19, retesting, even as part of a contact tracing investigation, is not necessary during the first three months after the date of symptom onset. When a positive test occurs less than three months after the persons symptom onset of their most recent illness, it is most likely that the positive test represents persistently positive test associated with the previous infection.

Whereas, if a positive test occurs more than three months after a persons symptom onset, then consider the possibility of re-infection, Dr Bhutani explains.

Prof R K Kochhar, head, Department of Gastroenterology, and Sub-Dean, PGIMER, says, We were earlier testing patients twice before releasing them, but now new studies and research have shown that viral shedding is very less after 10 days, so that means the patient will not be infectious and another isolation or quarantine is not needed and testing again is also not significant.

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Chandigarh News, download Indian Express App.

The Indian Express (P) Ltd

Visit link:

Viral shedding low after 10 days of Covid symptoms onset - The Indian Express

Read the Rest...

Teratec to Present the Latest Innovations in Simulation, HPC, Big Data and AI (Oct. 13-14) – HPCwire

§ September 22nd, 2020 § Filed under Quantum Medicine Comments Off on Teratec to Present the Latest Innovations in Simulation, HPC, Big Data and AI (Oct. 13-14) – HPCwire

Sept. 21, 2020 On October 13 and 14, digital version of the next Teratec Forum will present a review of the latest international advances in the fields of simulation, HPC (High Performance Computing), Big Data and artificial intelligence.

These technologies are more than ever at the forefront at a time when the need for analysis, research, prototyping, innovation is all the more necessary for the revival of industry and the economy. And they are taking such due place in sectors as varied as health, industry, aerospace, construction, and security.

The virtual exhibition will thus present latest technologies proposed by nearly 50 exhibitors (manufacturers and publishers, suppliers and integrators of hardware, software and services solutions, universities and research laboratories, centers of excellence, competence centers, European research projects, infrastructures and service platforms). Visitors wishing to deepen their knowledge, to attend demonstrations and be advised by best experts will be able to arrange for personalized appointments throughout the forum.

The plenary session will address major challenges facing French and European industry for which these innovative technologies will play a key role, with the participation of Thierry Breton, European Commissioner, Florence Parly, French Minister of the Armed Forces, Trish Damkroger, Vice President, Intel Data Center Group, Kevin D. Kissell, CTO, Google, as well as French and European industry leaders.

During the technical and application workshops, renowned international experts and industrialists will explain how they developed and implemented these innovative technologies on main themes of the digital twin in medicine, quantum computing, satellite data serving the environment, AI and scientific computing, Cloud computing and HPC, as well as Exascale.

Finally, the Numerical Simulation and AI Trophies will reward one innovative project or a company that has carried out an outstanding operation in the field of numerical simulation, high-performance computing, Big Data or AI. Added to our 5 usual trophies, an exceptional prize will be granted this year: the COVID-19 Trophy awarded to a product, technology or service providing an effective solution in the management or recovery from a health crisis such as COVID-19.

Registration and Information:https://teratec.eu/forum

Source: Teratec

Visit link:

Teratec to Present the Latest Innovations in Simulation, HPC, Big Data and AI (Oct. 13-14) - HPCwire

Read the Rest...

« Older Entries



Page 11234..»